Göran Källstrand

Title: Göran Källstrand: Innovator in Aerosol Drug Formulations

Introduction

Göran Källstrand is a notable inventor based in Bjärred, Sweden. He has made significant contributions to the field of aerosol drug formulations, particularly in the development of innovative inhalation therapies. His work has implications for improving the delivery of medications through pressurized metered dose inhalers.

Latest Patents

Göran Källstrand holds a patent for "Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides." This patent describes aerosol formulations that are suitable for use in pressurized metered dose inhalers. The formulations comprise a hydrofluoroalkane propellant, a medicament for inhalation, and a surfactant, which can be a C–C fatty acid or salt thereof, a bile salt, a phospholipid, or an alkyl saccharide. This innovation enhances the effectiveness of drug delivery systems.

Career Highlights

Källstrand is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on developing advanced therapeutic solutions that address various health challenges. His expertise in aerosol formulations has positioned him as a key player in the pharmaceutical industry.

Collaborations

Throughout his career, Göran Källstrand has collaborated with esteemed colleagues, including Kjell Bäckström and Magnus Dahlbäck. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of aerosol drug delivery technologies.

Conclusion

Göran Källstrand's contributions to aerosol drug formulations exemplify the impact of innovative thinking in the pharmaceutical industry. His patent and work at AstraZeneca highlight the importance of developing effective inhalation therapies for patients. His collaborations further enhance the potential for future advancements in this critical field.